Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma
Clinical trial NCT00663429 · COMPLETED
Trial details
- NCT number
- NCT00663429
- Sponsor
- Callisto Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2010-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.